(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
VPN Administrations for Online Protection - 2The most effective method to Keep up with Proficient Handshakes in a Computerized World
- 3NASA astronauts to return from space early due to an 'unexpected medical issue.' What happened — and when are they coming home?
- 4Interstellar comet 3I/ATLAS isn't an alien spacecraft, astronomers confirm. 'In the end, there were no surprises.'
- 56 Popular Men's Aromas On the planet
- Vote in favor of your Favored Travel Movement
- Find the Marvels of the World with These Travels
- Beating Scholastic Difficulties: Understudy Examples of overcoming adversity
- The EU Is Considering Lifting Tariffs on Chinese Electric Vehicles
- Pfizer says patient dies after receiving hemophilia drug in trial
- The Main 15 Applications for Efficiency and Association
- I'm 18 and founded an AI startup. I have to wake up at 3 a.m. to work on it before school, but it's worth every sleepless night.
- Knesset FADC extends emergency draft for 280,000 IDF reservists until January 1
- Famous SUVs With Low Energy Utilization In 2024
